Immunotherapy for Hepatocellular Carcinoma — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Immunotherapy for Hepatocellular Carcinoma — Stella

Recruiting

Back to Hepatocellular Carcinoma trials

Trial locations(1 site)

China

Jiangsu Province Hospital, Nanjing, Jiangsu

Key details

Sponsor

The First Affiliated Hospital with Nanjing Medical University

Enrollment target

~11,000 participants

Started

March 2024

Primary completion

December 2026

Age range

18 Years and older

Last updated April 2024

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov